ArticleScientific reports2026
Harnessing natural sunlight indoors: sensor-regulated therapeutic approach to enhance vitamin D status in humans.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Vitamin D and Intestinal Diseases: Impact on Intestinal Immunity and Gut Barrier Function.Diseases (Basel, Switzerland) · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vitamin D deficiency is a widespread global health issue, even in sun-rich regions like the United Arab Emirates (UAE), where environmental, behavioral, and cultural factors limit skin exposure to ultraviolet B (UVB) radiation. To address this, we developed and assessed a sensor-guided indoor sunlight reflection system that redirects natural sunlight indoors for controlled vitamin D synthesis. Sixteen healthy adults participated in a pre-post interventional study using this system, which features automated solar tracking and UV-index-based exposure control. Participants underwent four sessions weekly for eight weeks, each lasting 10–20 min depending on skin tone and UV intensity. Serum samples were taken at the start, middle, and end of the study. We measured eight vitamin D metabolites and epimers with a high-specificity LC-MS/MS workflow that differentiates 25(OH)D2/D3 and C-3 epimers. The intervention was associated with significant, time-dependent increases in serum 25(OH)D3, total 25-hydroxyvitamin D, and 1α,25-dihydroxyvitamin D3 [1α,25(OH)2D3] (p < 0.001 for all), with large effect sizes (partial η² = 0.35–0.44). Mean 25(OH)D3 increased from 1.99 to 4.11 ng/mL (+ 106%), total 25(OH)D from 5.0 to 7.7 ng/mL (+ 54%), and 1α 25(OH)2D3 from 0.33 to 0.74 ng/mL (+ 124%). Meanwhile, 25(OH)D2 and its epimer decreased slightly (-28% and − 30%), supporting endogenous D3 production from sunlight. No changes in 7α-hydroxycholesten-3-one (7αC4) suggested stable hepatic cholesterol breakdown. Throughout the study, no adverse events or safety issues occurred. Controlled indoor exposure to full-spectrum sunlight was associated with increased dermal vitamin D3 synthesis, providing physiological effects comparable to outdoor sunlight exposure without heat or overexposure risks. This study suggests that sensor-guided indoor full-spectrum sunlight exposure is a feasible and well-tolerated approach to improve vitamin D status in populations with limited sun exposure. By integrating optical engineering, biosafety algorithms, and precise analytics, this approach offers a potentially sustainable strategy for addressing vitamin D deficiency in indoor-living populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.